Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Titel:
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Auteur:
Home, Philip D Pocock, Stuart J Beck-Nielsen, Henning Curtis, Paula S Gomis, Ramon Hanefeld, Markolf Jones, Nigel P Komajda, Michel McMurray, John JV